At a glance
- Originator Bayer Schering Pharma
- Class Antiemetics
- Mechanism of Action AMPA receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 17 Jun 1999 New profile
- 17 Jun 1999 Discontinued-II for Stroke in Europe (Unknown route)